Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue, net $ 1,153,000 $ 411,000
Cost of revenue 858,000 348,000
Gross profit 295,000 63,000
Operating Expenses:    
Research and development 1,173,000 1,134,000
Sales and marketing 874,000 698,000
General and administrative 968,000 891,000
Total operating expenses 3,015,000 2,723,000
Loss from operations (2,720,000) (2,660,000)
Interest expense (3,000) (37,000)
Change in fair value of warrant liability 0 19,000
Warrant inducement expense (567,000) 0
Other expense, net (2,000) (2,000)
Loss before provision for income taxes (3,292,000) (2,680,000)
Provision for income taxes 0 0
Net loss (3,292,000) (2,680,000)
Convertible preferred stock dividend (20,000) (20,000)
Net loss attributable to common stockholders $ (3,312,000) $ (2,700,000)
Net loss per common share - basic and diluted $ (0.33) $ (2.19)
Weighted average number of common shares used in computing net loss per common share 9,979,991 1,230,598